Exhibit 10.40 INVESTMENT AND ROYALTY AGREEMENT This Investment and Royalty Agreement (this "Agreement") is made as of March 5, 2003, by and between Columbia Laboratories, Inc., a Delaware corporation ("Columbia"), and PharmaBio Development Inc., a...Investment and Royalty Agreement • March 31st, 2003 • Columbia Laboratories Inc • Pharmaceutical preparations • Delaware
ContractInvestment and Royalty Agreement • July 5th, 2019 • Sundial Growers Inc. • Medicinal chemicals & botanical products • Alberta
[***] Certain information in this document, marked by brackets, has been excluded pursuant to Item 601(b)(10)(iv) of Regulation S-K under the Securities Act of 1933, as amended, because it is both (i) not material and (ii) would likely cause competitive harm to the registrant if publicly disclosed.
Re: Second Amendment to Investment and Royalty AgreementInvestment and Royalty Agreement • July 24th, 2009 • Columbia Laboratories Inc • Pharmaceutical preparations • Delaware
Reference is made to that certain Investment and Royalty Agreement made as of March 5, 2003, as amended by a letter agreement dated January 26, 2004, and supplemented by a letter agreement dated April 14, 2006 (the “Striant Agreement”).
COLUMBIA LABORATORIES, INC. 354 Eisenhower Parkway Second Floor – Plaza I Livingston, NJ TEL: (973) 994-3999 FAX: (973) 994-3001Investment and Royalty Agreement • April 17th, 2006 • Columbia Laboratories Inc • Pharmaceutical preparations
